Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
| ▸ | CA3 | P07451 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CA5A | P35218 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | ACLY | P53396 | 1/20 | 0.39 |
| ▸ | NQO1 | P15559 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | HPGDS | O60760 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | COMT | P21964 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13018722 | 0.83 | CA9 (0.48) | HSD17B10HPGDLMNAHIF1ACA3 | |
| SCHEMBL10838459 | 0.83 | CA9 (0.46) | CA3CA6CA5ACA9CA14 | |
| SCHEMBL10590409 | 0.82 | PARP1 (0.41) | CA3CA6CA5ACA9CA14 | |
| SCHEMBL22396701 | 0.81 | CA3 (0.41) | CA3CA6CA5ACA9CA14 | |
| SCHEMBL3195282 | 0.80 | PKM (0.47) | CA3CA6CA5ACA9CA14 | |
| SCHEMBL31385189 | 0.79 | PTGS1 (0.60) | CA3CA6CA5ACA9CA14 | |
| Hydrochloric Acid SCHEMBL28046977 | 0.78 | PKM (0.46) | CA3CA6CA5ACA9CA14 | |
| SCHEMBL3935279 | 0.78 | PKM (0.46) | CA3CA6CA5ACA9CA14 | |
| Dobesilic Acid SCHEMBL232087 | 0.77 | LMNA (0.72) | HSD17B10HPGDLMNAHIF1ACA9 | |
| SCHEMBL1535883 | 0.77 | HSD17B10 (0.52) | HSD17B10HPGDLMNAHIF1AEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6441216-B1 | CHEMICAL INTERMEDIATES; ELECTROLYTES | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 2002-08-27 | — | — | US | claimed |
| CN-115901713-A | Circulating tumor cell detection method | 中国科学院宁波材料技术与工程研究所 | 2023-04-04 | — | — | CN | disclosed |
| CN-114736156-A | Preparation method and application of simplified derivatives of cryptolepine | 中捷四方生物科技股份有限公司 | 2022-07-12 | — | — | CN | disclosed |
| US-6864017-B2 | Method of preparing lithium complex salts for use in electrochemical cells | MERCK PATENT GMBH (DE) | 2005-03-08 | — | — | US | disclosed |
| CN-1177849-C | Method for preparing lithium matched salt for electrochemical cell | Ĭ��ר���ɷ�����˾ | 2004-12-01 | — | — | CN | disclosed |
| EP-1069128-B1 | Process for preparing complex lithium salts for use in electrochemical cells | MERCK PATENT GMBH (DE) | 2004-11-10 | — | — | EP | disclosed |
| US-20040091785-A1 | Method of preparing lithium complex salts for use in electrochemical cells | LEONOV ANDREI (DE) | 2004-05-13 | — | — | US | disclosed |
| US-6657072-B2 | O-sulfo-phenol where one or both of the groups is protected by a trialkylsilyl group, by reacting the phenol with chlorosulfonic acid and then with chlorotrimethylsilane; lithium bis(2-olato-benzenesulfonato(2)-O,O')borate(1-) | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 2003-12-02 | — | — | US | disclosed |
| US-20030028023-A1 | Method of preparing lithium complex salts for use in electrochemical cells | LEONOV ANDREI (DE) | 2003-02-06 | — | — | US | disclosed |
| US-6441216-B1 | CHEMICAL INTERMEDIATES; ELECTROLYTES | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 2002-08-27 | — | — | US | disclosed |
| EP-1069128-A2 | Process for preparing complex lithium salts for use in electrochemical cells | MERCK PATENT GmbH (DE) | 2001-01-17 | — | — | EP | disclosed |
| CN-1280130-A | Method for preparing lithium matched salt for electrochemical cell | MERCK PATENT GMBH (DE) | 2001-01-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030028023-A1 | Method of preparing lithium complex salts for use in electrochemical cells | CA3, MCU, CACNA2D3 | HSD17B10 2371/4885HPGD 2480/4885LMNA 58/4885 |
| US-20040091785-A1 | Method of preparing lithium complex salts for use in electrochemical cells | CA3, MCU, CACNA2D3 | HSD17B10 2371/4885HPGD 2480/4885LMNA 58/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.